Michael verret

Ph.D. (doctor), Regular member

Principal Interest
Rx (cannabis, opioids, ionic channels)

Secondary Interest
Epidemiology and pain trajectories

Primary Affiliation

Université Laval

Secondary Affiliation
Centre de recherche du Centre hospitalier universitaire de Québec-Université Laval (CHU de Québec - U. Laval)

Biography

Dr Michael Verret is an assistant professor in the Department of Anaesthesiology and Intensive Care at Université Laval and a researcher at the Centre de recherche du CHU de Québec-Université Laval in the Population Health and Optimal Health Practices research group. He practises anaesthesiology at the CHU de Québec-Université Laval. In 2024, he completed post-doctoral training in epidemiology at the University of Ottawa's Ottawa Hospital Research Institute. Dr Verret directs the research programme Optimizing Patient-centred outcomes Using opioid minimization Strategies (OPUS). The main objective of his programme is to describe, evaluate and guide perioperative clinical practices in the use of pharmacological and non-pharmacological co-analgesic strategies. The programme focuses on patient-oriented clinical outcomes such as quality of recovery and pain and its functional impact, with the aim of identifying effective alternatives to opioids that have a significant and lasting impact on surgical patients.

How does your current work contribute to improve treatment or understanding of pain?

As part of my research program Optimizing Patient-centred outcomes Using opioid minimization Strategies (OPUS), my main objective is to better guide perioperative clinical practices in using co-analgesic strategies. To do so, I focus on the evaluation of patient-centered clinical outcomes such as quality of recovery, pain and functional impact. It generates results with a significant and lasting impact on surgical patients.